PM
TWST icon

Prosight Management’s Twist Bioscience TWST Stock Holding History

Prosight Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-75,000
Closed -$2.11M – 51
2025
Q3 		$2.11M Buy
+75,000
New +$2.27M 0.49% 32

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Prosight Management's TWST Position: Q4 2025 in Review

Prosight Management sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 75,000 shares — an estimated $2.11M sold.

Prosight Management first reported a position in TWST in Q3 2025 and held it in 1 quarter. The position peaked at $2.11M in Q3 2025. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Prosight Management reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Prosight Management sold 75,000 Twist Bioscience shares in Q4 2025, an estimated $2.11M.
  • Prosight Management first reported a position in Twist Bioscience in Q3 2025 and held it in 1 quarter.
  • Prosight Management's Twist Bioscience position peaked at $2.11M in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Prosight Management's 13F filing for Q4 2025, filed 13 Feb 2026.